浙江大学医学院附属邵逸夫医院，又名浙江省邵逸夫医院，是附属于浙江大学医学部的一所三级甲等医院。设两个院区，庆春院区位于杭州市上城区庆春东路3号，地铁庆春广场站西侧。下沙院区位于杭州市钱塘区下沙路368号。两院区采用一体化管理模式，杭州公交298路在两院区之间互通。

During the past decade, Sir Run Run Shaw Hospital conducted 249 clinical trials. In the 10-year time frame, 249 clinical trials started and 38 clinical trials were completed, i.e. on average, 15.3% percent of trials that started reached the finish line to date. In the past 5 years, 139 clinical trials started and 26 clinical trials were completed. i.e. 18.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sir Run Run Shaw Hospital" #1 sponsor was "Hoffmann-La Roche" with 24 trials, followed by "Sir Run Run Shaw Hospital" with 24 trials sponsored, "BeiGene" with 15 trials sponsored, "Janssen Research & Development, LLC" with 15 trials sponsored and "Pfizer" with 15 trials sponsored. Other sponsors include 186 different institutions and companies that sponsored additional 115 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sir Run Run Shaw Hospital" #1 collaborator was "Sir Run Run Shaw Hospital" with 21 trials as a collaborator, "Shanghai Zhongshan Hospital" with 9 trials as a collaborator, "RenJi Hospital" with 6 trials as a collaborator, "The First Hospital of Jilin University" with 6 trials as a collaborator and "Anhui Provincial Hospital" with 5 trials as a collaborator. Other collaborators include 441 different institutions and companies that were collaborators in the rest 269 trials.

According to Clinical.Site data, the most researched conditions in "Sir Run Run Shaw Hospital" are "Gastric Cancer" (11 trials), "Non-Small Cell Lung Cancer" (10 trials), "Coronary Artery Disease" (9 trials), "Carcinoma, Non-Small-Cell Lung" (8 trials) and "Crohn Disease" (7 trials). Many other conditions were trialed in "Sir Run Run Shaw Hospital" in a lesser frequency.

Most popular intervention types in "Sir Run Run Shaw Hospital" are "Drug" (198 trials), "Device" (33 trials), "Other" (23 trials), "Procedure" (20 trials) and "Biological" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (54 trials), "Cisplatin" (18 trials), "Atezolizumab" (17 trials), "Capecitabine" (16 trials) and "Oxaliplatin" (13 trials). Other intervention names were less common.

The vast majority of trials in "Sir Run Run Shaw Hospital" are 271 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are 148 active trials in "Sir Run Run Shaw Hospital". 6 are not yet recruiting, 85 are recruiting, 55 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 79 completed trials in Sir Run Run Shaw Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Sir Run Run Shaw Hospital, 32 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 122 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 41 trials that are defined as “Not Applicable".